HOPE-Genomics Intervention for the Improvement of Cancer Patient Knowledge of Genomics

Summary

This clinical trial studies the effectiveness of a web-based cancer education tool called Helping Oncology Patients Explore Genomics (HOPE-Genomics) in improving patient knowledge of personal genomic testing results and cancer and genomics in general. HOPE-Genomics is a web-based education tool that teaches cancer/leukemia patients, and patients who may be at high-risk for developing cancer, about genomic testing and provide patients with information about their own genomic test results. The HOPE-Genomics tool may improve patient's genomic knowledge and quality of patient-centered care. In addition, it may also improve education and care quality for future patients.

Conditions

• Breast Carcinoma
• Colorectal Carcinoma
• Lung Carcinoma
• Malignant Solid Neoplasm
• Ovarian Carcinoma
• Pancreatic Carcinoma
• Prostate Carcinoma

Interventions

OTHER

Best Practice

Receive usual care

OTHER

Educational Intervention

View HOPE-Genomics tool after genomic test results are available

OTHER

Educational Intervention

View HOPE-Genomics before sequencing results are available

PROCEDURE

Genomic Profile

Receive genomics test results

OTHER

Survey Administration

Ancillary studies

Sponsors & Collaborators

• National Cancer Institute (NCI)

  collaborator NIH

• City of Hope Medical Center

  lead OTHER

Principal Investigators

• Stacy W Gray · City of Hope Comprehensive Cancer Center

Study Design

Allocation

RANDOMIZED

Purpose

SUPPORTIVE_CARE

Masking

NONE

Model

PARALLEL

Eligibility

Min Age

18 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-12-30

Primary Completion

2024-08-14

Completion

2026-06-15

Countries

• United States

Study Locations